2018-19 Section 7-Neoplastic and Inflammatory Diseases of the Head and Neck eBook

Oral Oncology 73 (2017) 152–159

K.Y. Zhan et al.

[12] Horne ZD, Glaser SM, Vargo JA, et al. Con fi rmation of proposed human papillo- mavirus risk-adapted staging according to AJCC/UICC TNM criteria for positive oropharyngeal carcinomas. Cancer 2016;122:2021 – 30 . [13] Groome PA, Schulze K, Boysen M, et al. A comparison of published head and neck stage groupings in laryngeal cancer using data from two countries. J Clin Epidemiol 2002;55:533 – 44 . [14] Sinha P, Lewis Jr JS, Piccirillo JF, Kallogjeri D, Haughey BH. Extracapsular spread and adjuvant therapy in human papillomavirus-related, p16-positive oropharyngeal carcinoma. Cancer 2012;118:3519 – 30 . [15] Sinha P, Kallogjeri D, Gay H, et al. High metastatic node number, not extracapsular spread or N-classi fi cation is a node-related prognosticator in transorally-resected, neck-dissected p16-positive oropharynx cancer. Oral Oncol 2015;51:514 – 20 . [16] Maxwell JH, Ferris RL, Gooding W, et al. Extracapsular spread in head and neck carcinoma: impact of site and human papillomavirus status. Cancer 2013;119:3302 – 8 . [17] Klozar J, Koslabova E, Kratochvil V, Salakova M, Tachezy R. Nodal status is not a prognostic factor in patients with HPV-positive oral/oropharyngeal tumors. J Surg Oncol 2013;107:625 – 33 . [18] Zenga J, Haughey BH, Jackson RS, et al. Outcomes of surgically treated human papillomavirus-related oropharyngeal squamous cell carcinoma with N3 disease. Laryngoscope 2016 . [19] An Y, Park HS, Kelly JR, et al. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma. Cancer 2017 . [20] Kumar B, Cipolla MJ, Old MO, et al. Surgical management of oropharyngeal squamous cell carcinoma: Survival and functional outcomes. Head Neck 2016;38(Suppl 1):E1794 – 802 . [21] Mermod M, Tolstonog G, Simon C, Monnier Y. Extracapsular spread in head and neck squamous cell carcinoma: A systematic review and meta-analysis. Oral Oncol 2016;62:60 – 71 . [22] Haughey BH, Sinha P. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer. Laryngoscope 2012;122(Suppl 2):S13 – 33 .

References

[1] Chaturvedi AK, Engels EA, Pfei ff er RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 2011;29:4294 – 301 . [2] Spector ME, Gallagher KK, Bellile E, et al. Patterns of nodal metastasis and prognosis in human papillomavirus-positive oropharyngeal squamous cell carcinoma. Head Neck 2014;36:1233 – 40 . [3] O'Sullivan B, Huang SH, Su J, et al. Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study. Lancet Oncol 2016;17:440 – 51 . [4] Huang SH, Xu W, Waldron J, et al. Re fi ning American joint committee on cancer/ union for international cancer control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas. J Clin Oncol 2015;33:836 – 45 . [5] Dahlstrom KR, Garden AS, William Jr WN, Lim MY, Sturgis EM. Proposed staging system for patients with HPV-related oropharyngeal cancer based on nasophar- yngeal cancer N categories. J Clin Oncol 2016;34:1848 – 54 . [6] Kelly JR, Husain ZA, Burtness B. Treatment de-intensi fi cation strategies for head and neck cancer. Eur J Cancer 2016;68:125 – 33 . [7] Lydiatt WM, Patel SG, O'Sullivan B, et al. Head and neck cancers-major changes in the American joint committee on cancer eighth edition cancer staging manual. CA Cancer J Clin 2017;67:122 – 37 . [8] Haughey BH, Sinha P, Kallogjeri D, et al. Pathology-based staging for HPV-positive squamous carcinoma of the oropharynx. Oral Oncol 2016;62:11 – 9 . [9] NCCN guidelines for head and neck cancer care; 2017. Available from URL: http:// www.nccn.org/professionals/physician_gls/PDF/head-and-neck.pdf . [10] Bilimoria KY, Stewart AK, Winchester DP, Ko CY. The national cancer data base: a powerful initiative to improve cancer care in the United States. Ann Surg Oncol 2008;15:683 – 90 . [11] Requesting a cancer program category change; 2017. Available from URL: https:// www.facs.org/quality-programs/cancer/coc/apply/categories .

183